UBS Group’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.96M | Buy |
93,400
+30,800
| +49% | +$2.75M | ﹤0.01% | 3599 |
|
|
2025
Q4 | $4.95M | Sell |
62,600
-90,500
| -59% | -$7.1M | ﹤0.01% | 4043 |
|
|
2025
Q3 | $12.2M | Hold |
153,100
| – | – | ﹤0.01% | 3080 |
|
|
2025
Q2 | $13.9M | Buy |
153,100
+143,100
| +1,431% | +$13.1M | ﹤0.01% | 2763 |
|
|
2025
Q1 | $937K | Sell |
10,000
-381,500
| -97% | -$34.2M | ﹤0.01% | 5332 |
|
|
2024
Q4 | $35.6M | Buy |
391,500
+27,000
| +7% | +$2.58M | 0.01% | 1771 |
|
|
2024
Q3 | $37.8M | Buy |
364,500
+30,000
| +9% | +$3.06M | 0.01% | 1358 |
|
|
2024
Q2 | $32.5M | Sell |
334,500
-112,200
| -25% | -$10.4M | 0.01% | 1327 |
|
|
2024
Q1 | $40.2M | Sell |
446,700
-364,800
| -45% | -$30.9M | 0.01% | 1180 |
|
|
2023
Q4 | $64.7M | Buy |
811,500
+72,500
| +10% | +$5.45M | 0.02% | 818 |
|
|
2023
Q3 | $52.6M | Buy |
739,000
+169,600
| +30% | +$12.7M | 0.02% | 814 |
|
|
2023
Q2 | $43.9M | Buy |
569,400
+468,700
| +465% | +$36.3M | 0.01% | 907 |
|
|
2023
Q1 | $7.57M | Sell |
100,700
-6,200
| -6% | -$461K | ﹤0.01% | 2135 |
|
|
2022
Q4 | $8.42M | Sell |
106,900
-200
| -0.2% | -$15K | ﹤0.01% | 2043 |
|
|
2022
Q3 | $7.52M | Sell |
107,100
-14,200
| -12% | -$1.11M | ﹤0.01% | 2021 |
|
|
2022
Q2 | $9.72M | Sell |
121,300
-161,800
| -57% | -$12.7M | ﹤0.01% | 1844 |
|
|
2022
Q1 | $21.5M | Buy |
283,100
+136,200
| +93% | +$10.8M | 0.01% | 1364 |
|
|
2021
Q4 | $12.5M | Buy |
146,900
+2,876
| +2% | +$225K | ﹤0.01% | 1953 |
|
|
2021
Q3 | $10.9M | Buy |
144,024
+90,400
| +169% | +$7.18M | ﹤0.01% | 1961 |
|
|
2021
Q2 | $4.36M | Sell |
53,624
-119,179
| -69% | -$9.74M | ﹤0.01% | 2837 |
|
|
2021
Q1 | $13.6M | Buy |
172,803
+65,603
| +61% | +$5.14M | ﹤0.01% | 1703 |
|
|
2020
Q4 | $9.17M | Sell |
107,200
-110,600
| -51% | -$9.15M | ﹤0.01% | 1916 |
|
|
2020
Q3 | $16.8M | Sell |
217,800
-38,200
| -15% | -$2.91M | 0.01% | 1289 |
|
|
2020
Q2 | $18.8M | Buy |
256,000
+190,600
| +291% | +$13.5M | 0.01% | 1123 |
|
|
2020
Q1 | $4.34M | Sell |
65,400
-90,600
| -58% | -$6.39M | ﹤0.01% | 2052 |
|
|
2019
Q4 | $10.7M | Buy |
156,000
+38,700
| +33% | +$2.64M | ﹤0.01% | 1893 |
|
|
2019
Q3 | $8.62M | Buy |
117,300
+41,300
| +54% | +$3M | ﹤0.01% | 1885 |
|
|
2019
Q2 | $5.45M | Buy |
76,000
+38,000
| +100% | +$2.7M | ﹤0.01% | 2254 |
|
|
2019
Q1 | $2.6M | Sell |
38,000
-2,300
| -6% | -$149K | ﹤0.01% | 2757 |
|
|
2018
Q4 | $2.4M | Sell |
40,300
-160,200
| -80% | -$10M | ﹤0.01% | 2858 |
|
|
2018
Q3 | $13.4M | Sell |
200,500
-600
| -0.3% | -$40K | 0.01% | 1531 |
|
|
2018
Q2 | $13M | Buy |
201,100
+196,300
| +4,090% | +$12.8M | 0.01% | 1512 |
|
|
2018
Q1 | $344K | Buy |
4,800
+2,500
| +109% | +$180K | ﹤0.01% | 4443 |
|
|
2017
Q4 | $174K | Sell |
2,300
-100
| -4% | -$7.3K | ﹤0.01% | 5010 |
|
|
2017
Q3 | $175K | Sell |
2,400
-1,300
| -35% | -$93.7K | ﹤0.01% | 4936 |
|
|
2017
Q2 | $274K | Sell |
3,700
-29,400
| -89% | -$2.18M | ﹤0.01% | 4544 |
|
|
2017
Q1 | $2.42M | Sell |
33,100
-29,400
| -47% | -$2.06M | ﹤0.01% | 2762 |
|
|
2016
Q4 | $4.09M | Buy |
62,500
+3,500
| +6% | +$240K | ﹤0.01% | 2281 |
|
|
2016
Q3 | $4.37M | Buy |
59,000
+1,300
| +2% | +$96.1K | ﹤0.01% | 2144 |
|
|
2016
Q2 | $4.22M | Sell |
57,700
-37,300
| -39% | -$2.66M | ﹤0.01% | 2091 |
|
|
2016
Q1 | $6.71M | Sell |
95,000
-176,200
| -65% | -$11.7M | ﹤0.01% | 1614 |
|
|
2015
Q4 | $18.1M | Buy |
271,200
+230,700
| +570% | +$15.3M | 0.01% | 1016 |
|
|
2015
Q3 | $2.57M | Buy |
40,500
+1,000
| +3% | +$65.3K | ﹤0.01% | 2517 |
|
|
2015
Q2 | $2.58M | Sell |
39,500
-1,500
| -4% | -$102K | ﹤0.01% | 2731 |
|
|
2015
Q1 | $2.84M | Sell |
41,000
-7,400
| -15% | -$511K | ﹤0.01% | 2601 |
|
|
2014
Q4 | $3.35M | Buy |
+48,400
| New | +$3.27M | ﹤0.01% | 2423 |
|
Other funds holding CL
VCM
DAM
VPM
UBS Group's CL Position: Q1 2026 in Review
UBS Group increased its Colgate-Palmolive (CL) stake by 1.4% in Q1 2026, buying an estimated $5.7M and bringing the position to 4,614,605 shares worth $393M. The position accounts for 0.06% of the portfolio, ranked #336.
UBS Group first reported a position in CL in Q4 2014 and has held it in 46 quarters since. The position peaked at $977M in Q1 2018. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- UBS Group held 4,614,605 shares of Colgate-Palmolive worth $393M as of Q1 2026.
- UBS Group bought 63,913 Colgate-Palmolive shares in Q1 2026, an estimated $5.7M.
- Colgate-Palmolive made up 0.06% of UBS Group's portfolio in Q1 2026, its #336 holding.
- UBS Group first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Colgate-Palmolive position peaked at $977M in Q1 2018.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.